VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TMDX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TMDXTransMedics Group, Inc.
$67.29$2.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTMDXQuarterly Financials

TransMedics Group, Inc. (TMDX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

TransMedics Group, Inc. (TMDX) quarterly income statement — complete revenue, gross profit & net income history

TMDX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue173.93M160.76M143.82M157.37M143.54M121.62M108.76M114.31M96.85M81.17M66.43M52.47M41.55M31.38M25.68M20.52M15.88M9.67M5.37M8.17M
Revenue Growth %21.18%32.18%32.24%37.68%48.21%49.83%63.72%117.87%133.07%158.72%158.65%155.66%161.68%224.52%378.27%151.14%125.15%26.76%-24.27%140.96%
Cost of Goods Sold72.77M67.35M59.25M60.78M55.31M49.61M47.92M45.14M36.99M33.25M25.77M15.72M12.79M10.67M7.57M6.17M3.78M2.68M1.6M2.58M
COGS % of Revenue41.84%41.89%41.2%38.62%38.53%40.79%44.06%39.49%38.19%40.96%38.79%29.97%30.77%34.01%29.47%30.07%23.78%27.74%29.74%31.6%
Gross Profit101.16M93.41M84.58M96.59M88.23M72.01M60.84M69.16M59.86M47.92M40.66M36.74M28.77M20.7M18.11M14.35M12.1M6.99M3.77M5.59M
Gross Margin %58.16%58.11%58.8%61.38%61.47%59.21%55.94%60.51%61.81%59.04%61.21%70.03%69.23%65.99%70.53%69.93%76.22%72.26%70.26%68.4%
Gross Profit Growth %14.66%29.72%39%39.66%47.39%50.27%49.64%88.24%108.1%131.48%124.47%156.03%137.66%196.35%380.12%156.75%151.59%44.7%-25.11%192.77%
Operating Expenses87.86M72.14M61.27M60.02M60.78M63.37M56.92M56.65M47.44M45.32M69M37.65M30.86M27.48M23.66M24.09M21.47M18.31M15.5M15.46M
OpEx % of Revenue50.52%44.87%42.6%38.14%42.35%52.1%52.34%49.56%48.98%55.83%103.86%71.76%74.25%87.59%92.12%117.42%135.22%189.43%288.6%189.17%
Selling, General & Admin62.98M51.44M46.02M44.09M43.63M46.91M42.66M42.8M36.06M34.56M30.65M29.36M24.98M21.73M16.85M17.38M13.94M12M10.34M9.16M
SG&A % of Revenue36.21%32%31.99%28.02%30.39%38.57%39.22%37.44%37.23%42.58%46.14%55.95%60.12%69.25%65.61%84.7%87.78%124.12%192.46%112.13%
Research & Development24.88M20.7M15.26M15.93M17.16M16.46M14.27M13.86M11.38M10.76M38.34M8.29M5.87M5.76M6.81M6.71M7.53M6.31M5.16M6.29M
R&D % of Revenue14.3%12.88%10.61%10.13%11.96%13.54%13.12%12.12%11.75%13.26%57.72%15.8%14.13%18.35%26.51%32.72%47.44%65.31%96.15%77.04%
Other Operating Expenses00000000000000000000
Operating Income13.3M21.27M23.3M36.57M27.44M8.64M3.92M12.51M12.42M2.6M-28.34M-906K-2.09M-6.78M-5.54M-9.74M-9.37M-11.33M-11.72M-9.87M
Operating Margin %7.64%13.23%16.2%23.24%19.12%7.11%3.61%10.94%12.83%3.21%-42.65%-1.73%-5.03%-21.61%-21.59%-47.49%-59%-117.17%-218.34%-120.77%
Operating Income Growth %-51.55%146.1%493.93%192.35%120.94%232.08%113.85%1480.57%694.59%138.4%-411.09%90.7%77.7%40.16%52.72%1.25%-43.98%-92.13%-154.34%-25.53%
EBITDA13.3M28.74M30.15M43.3M33.58M14.32M9.1M17.11M16.82M6.21M-26.44M486K-802K-5.49M-4.65M-8.95M-8.86M-10.86M-11.27M-9.42M
EBITDA Margin %7.64%17.88%20.96%27.51%23.39%11.78%8.37%14.97%17.37%7.65%-39.8%0.93%-1.93%-17.51%-18.12%-43.61%-55.81%-112.35%-209.87%-115.25%
EBITDA Growth %-60.4%100.65%231.31%153.1%99.61%130.73%134.41%3419.96%2197.63%213%-468.28%105.43%90.95%49.42%58.71%4.96%-46.19%-98.72%-167.82%-25.78%
D&A (Non-Cash Add-back)07.47M6.85M6.73M6.14M5.68M5.18M4.6M4.4M3.6M1.89M1.39M1.29M1.28M891K795K507K466K455K451K
EBIT13.3M24.99M26.52M39.66M30.14M10.56M7.86M15.78M15.99M7.47M-23.34M1.52M-1.53M-5.69M-6.62M-10.53M-9.6M-11.67M-11.97M-9.7M
Net Interest Income0-3.35M-3.49M-976K-3.46M-655K-317K-223K-28K1.16M1.61M-74K-536K78K-387K-872K-960K-978K-979K-794K
Interest Income0002.5M02.92M3.3M3.4M3.57M4.76M5.2M2.43M555K1.08M400K0000171K
Interest Expense-7.17M3.35M3.49M3.48M3.46M3.57M3.62M3.62M3.6M3.6M3.59M2.5M1.09M1.01M787K872K960K978K979K965K
Other Income/Expense-4.81M360K-269K-385K-767K-1.66M322K-355K-28K1.26M1.41M-74K-536K78K-1.86M-1.76M-1.19M-1.32M-1.23M-794K
Pretax Income8.48M21.63M23.03M36.18M26.68M6.99M4.25M12.15M12.39M3.86M-26.93M-980K-2.63M-6.7M-7.41M-11.5M-10.56M-12.65M-12.95M-10.66M
Pretax Margin %4.88%13.46%16.01%22.99%18.58%5.75%3.9%10.63%12.8%4.76%-40.54%-1.87%-6.32%-21.36%-28.84%-56.05%-66.47%-130.85%-241.21%-130.49%
Income Tax-1.17M-83.75M-1.29M1.27M994K132K29K-41K196K-168K-1.51M21K11K19K19K22K6K17K9K6K
Effective Tax Rate %-13.79%-387.14%-5.59%3.52%3.73%1.89%0.68%-0.34%1.58%-4.35%5.6%-2.14%-0.42%-0.28%-0.26%-0.19%-0.06%-0.13%-0.07%-0.06%
Net Income7.32M105.38M24.32M34.91M25.68M6.86M4.22M12.19M12.2M4.03M-25.42M-1M-2.64M-6.72M-7.43M-11.52M-10.56M-12.67M-12.96M-10.67M
Net Margin %4.21%65.55%16.91%22.18%17.89%5.64%3.88%10.67%12.59%4.97%-38.27%-1.91%-6.34%-21.42%-28.91%-56.15%-66.51%-131.03%-241.38%-130.56%
Net Income Growth %-71.52%1436.87%476.83%186.26%110.56%70.11%116.58%1318.18%562.71%159.99%-242.34%91.31%75.04%46.95%42.71%-8.01%-33.41%-100.73%-154.76%-25.55%
Net Income (Continuing)7.32M105.38M24.32M34.91M25.68M6.86M4.22M12.19M12.2M4.03M-25.42M-1M-2.64M-6.72M-7.43M-11.52M-10.56M-12.67M-12.96M-10.67M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.202.590.660.920.700.190.120.350.350.12-0.78-0.03-0.08-0.21-0.25-0.41-0.38-0.46-0.47-0.39
EPS Growth %-71.43%1263.16%450%162.86%100%58.33%115.38%1236.36%528.4%157.14%-212%92.49%78.5%54.35%46.81%-5.13%-31.03%-100%-147.37%-8.33%
EPS (Basic)0.213.080.711.030.760.200.130.370.370.12-0.78-0.03-0.08-0.21-0.25-0.41-0.38-0.46-0.47-0.39
Diluted Shares Outstanding36.19M40.93M40.75M40.56M39.91M35.21M35.68M35.29M34.68M34.18M32.61M32.55M32.26M32.01M30.23M27.98M27.95M27.77M27.7M27.62M
Basic Shares Outstanding34.38M34.22M34.11M33.91M33.72M33.59M33.44M33.12M32.76M32.64M32.61M32.55M32.26M32.01M30.23M27.98M27.79M27.77M27.7M27.62M
Dividend Payout Ratio--------------------